DOJ files statement of interest in suit against Pfizer
Pharma Compliance Alert, May 21, 2008
The Department of Justice (DOJ) filed a statement of interest in a whistleblower lawsuits brought by former Pfizer Vice President Peter Rost against Pfizer.
Rost’s suit alleges Pharmacia, which Pfizer bought, marketed Genotropin, a human growth hormone, for off-label uses. Pfizer said fraud was not involved because Genotropin was listed in three major pharmaceutical compendia so state Medicaid programs would likely be required to issue reimbursements anyway.
The DOJ, which originally declined to join the lawsuit, filed a statement of interest in the U.S. District Court in Massachusetts. The DOJ presents four arguments against Pfizer’s position:
- A listing in a compendium is not the same as being supported by the compendium citation
- Even if an off-label use is supported, other grounds for a false claim may exist
- A complaint does not need to allege the defendants made the false claim
- The identification of a specific false claim is not required to satisfy the particularity requirement
Comments
0 comments on “DOJ files statement of interest in suit against Pfizer ”
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- HIPAA Q&A: Level of encryption needed for email
- Case Management Monthly, June 2012
- Searched